Acrospire Investment Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-4,007	Closed	-$12K	–	2366
2017 Q1	$12K	Sell	4,007 -2,742	-41%	-$8.21K	0.01%	1826
2016 Q4	$21K	Buy	+6,749	New	+$21K	0.01%	1743